Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
| Data(s) |
01/01/2003
|
|---|---|
| Resumo |
Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure. |
| Identificador |
http://dx.doi.org/10.1093/annonc/mdg020 http://www.scopus.com/inward/record.url?scp=0037250290&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
O'Sullivan , J , Huddart , R A , Norman , A R , Nicholls , J , Dearnaley , D P & Horwich , A 2003 , ' Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours ' Annals of Oncology , vol 14 , no. 1 , pp. 91-96 . DOI: 10.1093/annonc/mdg020 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology |
| Tipo |
article |
